Clinical Trial Update: Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 safety study extension for Iloprost Power 15 in pulmonary arterial hypertension. Results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Iloprost Power 15 (iloprost)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-10-29